Targeted chimeric molecules for cancer therapy

Details for Australian Patent Application No. 2006203850 (hide)

Owner Research Development Foundation

Inventors Rosenblum, Michael G.; Ellington, Andrew D.

Agent Pizzeys

Pub. Number AU-A-2006203850

PCT Pub. Number WO2006/074451

Priority 60/643,337 10.01.05 US

Filing date 10 January 2006

Wipo publication date 13 July 2006

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/32 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

26 July 2007 PCT application entered the National Phase

  PCT publication WO2006/074451 Priority application(s): WO2006/074451

17 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006203851-Regulation of CCN2 by CCN3 and its therapeutic and diagnostic potential in fibrosis, sclerosis and other diseases

2006203845-Novel heteropyrrole analogs acting on cannabiniod receptors